1. Home
  2. RDHL vs YJ Comparison

RDHL vs YJ Comparison

Compare RDHL & YJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • YJ
  • Stock Information
  • Founded
  • RDHL 2009
  • YJ 2015
  • Country
  • RDHL Israel
  • YJ China
  • Employees
  • RDHL N/A
  • YJ N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • YJ Other Specialty Stores
  • Sector
  • RDHL Health Care
  • YJ Consumer Discretionary
  • Exchange
  • RDHL Nasdaq
  • YJ Nasdaq
  • Market Cap
  • RDHL 8.2M
  • YJ 8.8M
  • IPO Year
  • RDHL N/A
  • YJ 2019
  • Fundamental
  • Price
  • RDHL $5.58
  • YJ $1.73
  • Analyst Decision
  • RDHL
  • YJ
  • Analyst Count
  • RDHL 0
  • YJ 0
  • Target Price
  • RDHL N/A
  • YJ N/A
  • AVG Volume (30 Days)
  • RDHL 10.4K
  • YJ 45.2K
  • Earning Date
  • RDHL 04-07-2025
  • YJ 03-20-2025
  • Dividend Yield
  • RDHL N/A
  • YJ N/A
  • EPS Growth
  • RDHL N/A
  • YJ N/A
  • EPS
  • RDHL N/A
  • YJ N/A
  • Revenue
  • RDHL $3,707,000.00
  • YJ $66,957,730.00
  • Revenue This Year
  • RDHL $224.90
  • YJ N/A
  • Revenue Next Year
  • RDHL $82.69
  • YJ N/A
  • P/E Ratio
  • RDHL N/A
  • YJ N/A
  • Revenue Growth
  • RDHL N/A
  • YJ N/A
  • 52 Week Low
  • RDHL $5.41
  • YJ $1.42
  • 52 Week High
  • RDHL $20.28
  • YJ $4.72
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 35.64
  • YJ 53.54
  • Support Level
  • RDHL $5.50
  • YJ $1.68
  • Resistance Level
  • RDHL $6.26
  • YJ $1.93
  • Average True Range (ATR)
  • RDHL 0.32
  • YJ 0.13
  • MACD
  • RDHL -0.02
  • YJ 0.02
  • Stochastic Oscillator
  • RDHL 3.08
  • YJ 69.70

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

About YJ Yunji Inc. American Depository Shares

Yunji Inc is a social e-commerce platform in China that offers a membership-based model that leverages the power of social interaction. The company provides a host of selected commodities such as beauty and personal care, mobile phones and digital products, baby and maternal products, toys, fruits, and other fresh products. It has expanded to operate its business, including the marketplace, on a diverse range of sales channels and other platforms. Geographically, the firm operates in China.

Share on Social Networks: